JLK, Inc. engages in the development of artificial intelligence-based stroke treatment solutions. It provides early diagnosis of diseases, assistance with reading, lesion detection, and prognosis prediction through medical imaging and clinical data analysis using artificial intelligence. The company was founded by Won-Tae Kim on February 18, 2014 and is headquartered in Cheongju-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company